Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
Open Access
- 19 March 2010
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 12 (2), 104
- https://doi.org/10.1186/bcr2483
Abstract
There is a strong association between BRCA1 mutation carrier status and estrogen receptor-negative breast cancer. This has led to the idea that estrogen receptor-positive breast cancers in BRCA1 mutation carriers may be incidental or sporadic in nature and not as a direct result of BRCA1 dysfunction. A recent paper in Breast Cancer Research challenges this view.This publication has 9 references indexed in Scilit:
- Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic featuresBreast Cancer Research, 2010
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriersNature Medicine, 2009
- Molecular Basis for Estrogen Receptor Deficiency in BRCA1-Linked Breast CancerJNCI Journal of the National Cancer Institute, 2007
- Estrogen Receptor Status in BRCA1 - and BRCA2 -Related Breast CancerClinical Cancer Research, 2004
- Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.2001
- Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studyThe Lancet, 2000
- Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation CarriersJNCI Journal of the National Cancer Institute, 1999
- Estrogen and Progesterone Receptor Determinations in Breast Cancer—Technology, Biology and Clinical SignificanceActa Oncologica, 1988
- Oestrogen receptors in primary and advanced breast cancer: An eight year review of 704 casesBritish Journal of Cancer, 1987